Cinnamon for Type 2 Diabetes

Verdict: Weak, inconsistent evidence; not recommended

Cinnamon is not a reliable treatment for type 2 diabetes. It may lower fasting blood sugar modestly, but its effect on long-term control (HbA1c) is small and inconsistent, and major health authorities do not recommend it for managing blood glucose.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade is Weak (C) because the trial evidence pulls in different directions. The 2012 Cochrane review of 10 RCTs (PMID 22972104, n=577) found no significant effect on HbA1c, insulin, or post-meal glucose and called the fasting-glucose data inconclusive amid high risk of bias. A 2013 review (PMID 24019277, n=543) saw fasting glucose fall about 25 mg/dL but no HbA1c change, while later meta-analyses (PMID 37818728; PMID 38917435, n=3054) and a 2025 umbrella review (PMC12620228) report small significant drops in both. These conflicting results stem from different study pools and high heterogeneity.

Where there is a signal, it is limited. Fasting-glucose improvements are fairly consistent (the umbrella review rated them 'highly suggestive' at I-squared=0%) but clinically modest at roughly 15 mg/dL, and that same review flagged HbA1c and insulin-resistance findings as needing caution. A triple-blind RCT (PMID 33605836, n=160) found only a 0.2% HbA1c drop over three months. Optimal dose, formulation, and duration remain unclear.

Health authorities reinforce the cautious read. The US FDA treats cinnamon only as a flavoring agent with no approved health claim, and the WHO endorses it solely for poor appetite and indigestion, not blood sugar. The Mayo Clinic says the evidence is not strong enough to recommend it, with Cleveland Clinic, Harvard, and diabetes specialty guidance similarly unconvinced. Cassia cinnamon also contains coumarin, a liver toxin at high intake, and can interact with glucose-lowering drugs, so it should not replace proven diabetes care.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.43
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
78%
Broadly consistent
Evidence level
E1
Cochrane high-quality SR/MA

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.35
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.435
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (4 篇 > 1 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (6)L2 · primary research & systematic reviews

Cinnamon for diabetes mellitus (Cochrane Review)
PMID: 22972104 2012 系統性回顧 n = 577
Finding: Effect on FBG inconclusive; no significant difference in HbA1c, insulin, or postprandial glucose; high/unclear risk of bias in most trials.
🟢 High quality Academic
View on PubMed
Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis
PMID: 24019277 2013 系統性回顧 n = 543
Finding: FBG significantly reduced (WMD -24.59 mg/dL); HbA1c not significantly reduced (-0.16%); high heterogeneity limits applicability.
Effect size: WMD FBG -24.59 mg/dL; HbA1c WMD -0.16% (ns)
View on PubMed
Efficacy of Cinnamon as an Adjuvant in Reducing the Glycemic Biomarkers of Type 2 Diabetes Mellitus: A Three-Month, Randomized, Triple-Blind, Placebo-Controlled Clini
PMID: 33605836 2022 RCT (double-blind) n = 160
Finding: Cinnamon group showed statistically significant reductions of 0.2% HbA1c and 0.55 mmol/L FBG versus placebo at 90 days.
Government Effect size: MD HbA1c -0.2%; MD FBG -0.55 mmol/L
View on PubMed
The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of RCTs
PMID: 37818728 2024 系統性回顧
Finding: Cinnamon significantly reduced FBG (SMD -1.32; 95% CI -1.77 to -0.87; p<0.001) and HbA1c (SMD -0.67; 95% CI -1.18 to -0.15; p=0.011).
Effect size: SMD FBG -1.32; SMD HbA1c -0.67
View on PubMed
Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes: a systematic review and meta-analysis
PMID: 38917435 2025 系統性回顧 n = 3,054
Finding: Cinnamon reduced FBG (WMD -15.26 mg/dL; 95% CI -22.23 to -8.30) and HbA1c at <=2 g/day (WMD -0.68%; 95% CI -1.16 to -0.10); high heterogeneity across studies.
Effect size: WMD FBG -15.26 mg/dL; WMD HbA1c -0.68%
View on PubMed
The effects of cinnamon on patients with metabolic diseases: an umbrella review of meta-analyses of randomized controlled trials
PMID: 2025 系統性回顧
— See PubMed for details
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
FLAVORING AGENT OR ADJUVANT source↗
L4b EU EFSA
Cautious
L4d TW TFDA / 衛福部
Cautious
目前並沒有足夠的實證顯示吃肉桂可以達到降血糖的功效,肉桂不能取代任何降血糖藥物。 source↗
L4e WHO
Supportive
WHO Monographs on Selected Medicinal Plants, Volume 1 (Geneva: WHO, 1999), Cortex Cinnamomi (p. 95): Indications — loss of appetite and dyspeptic complaints. Daily dose: 2.0–4.0 g of the drug, or 0.05–0.2 g essential oil in appropriate preparations. source↗
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Neutral
Despite many studies, it isn't clear whether cinnamon helps lower blood sugar in people with diabetes. Some studies of cinnamon have shown a benefit, while others haven't, and many of those research studies included different doses and different types. Currently, there is not strong enough evidence to solely recommend cinnamon to people with diabetes for medicinal purposes. source↗
L5c Cleveland Clinic
Cautious
L5d Harvard Health
Cautious
L5e Specialty Society (condition-mapped)
Against
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬6 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-type2-diabetes-INT-cinnamon-001 繁體中文版 →